UOTTAIMCU
ALXN

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Alexion Pharmaceuticals ALXN Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40
Closed -$5K – 42
2016
Q4 		$5K Buy
+40
New +$4.89K 0.01% 25

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s ALXN Position: Q1 2017 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Alexion Pharmaceuticals (ALXN) in Q1 2017, closing a stake of 40 shares — an estimated $5K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in ALXN in Q4 2016 and held it in 1 quarter. The position peaked at $5K in Q4 2016. 561 funds tracked by Wall St. Rank hold ALXN as of Q1 2017.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Alexion Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 40 Alexion Pharmaceuticals shares in Q1 2017, an estimated $5K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Alexion Pharmaceuticals position peaked at $5K in Q4 2016.
  • 561 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2017.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2017, filed 20 Apr 2017.